Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-070514

NOVELION THERAPEUTICS INC. · NVLN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 17, 2016
Accepted (ET)
Jun 21, 2016 · 9:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F1,F2$1.43Jun 17, 2016A50,000A—Jun 17, 2026Common stock50,00050,000D
Phantom StockF3,F7,F4,F5,F6—Jun 17, 2016A6,400A——Common stock6,40028,400D

Explanation of responses